2001
DOI: 10.4049/jimmunol.167.9.4910
|View full text |Cite
|
Sign up to set email alerts
|

Bryostatin-1 Specifically Inhibits In Vitro IgE Synthesis

Abstract: Bryostatin-1, a macrocyclic lactone, is an antineoplastic agent that potently activates protein kinase C. Bryostatin-1 (Bryo) had an immunomodulatory effect on murine B cells in that it specifically inhibited IgE production. IgE levels were inhibited in a B cell dose-response curve, whereas IgM and IgG1 were induced by Bryo treatment. Taken together, ELISPOT and surface Ig staining data suggested that Bryo inhibition occurred at the level of class switching. RT-PCR and real time PCR data showed that this inhib… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2002
2002
2009
2009

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 48 publications
(43 reference statements)
0
7
0
Order By: Relevance
“…1b). 21,22 Switching to IgE is not affected by increasing the B‐cell dose. Both germline transcription (data not shown) and expression of the mature IgE transcript on the cell surface (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…1b). 21,22 Switching to IgE is not affected by increasing the B‐cell dose. Both germline transcription (data not shown) and expression of the mature IgE transcript on the cell surface (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…PKC activity, with the active site usually located at the Cterminus to phosphorylate serine and threonine residues, is mediated by a family of at least twelve PKC isoforms [20][21][22] (Fig. 1).…”
Section: Protein Kinase C Isoforms and Molecular Targetsmentioning
confidence: 99%
“…IgM, IgG and IgE levels were measured as described previously 33. Micro‐titer plates were coated overnight at 4 °C with anti‐human IgE Ab, anti‐human IgG and anti‐human IgM, respectively.…”
Section: Methodsmentioning
confidence: 99%